MARVELD1 and hepatocellular carcinoma: In addition to that, previous studies have found that MARVEL domain-containing 1 (MARVELD1) could inhibit tumor cell proliferation and enhance the sensitivity to chemotherapeutic drugs in hepatocellular carcinoma (Zhang et al., 2019).